Folate intake, MTHFR polymorphisms, and the risk of colorectal cancer: A systematic review and meta-analysis

Journal of Cancer Epidemiology

Volumn , Issue , 2012, Pages

  Kennedy, Deborah A ^a,b   Stern, Seth J ^a,c   Matok, Ilan ^a   Moretti, Myla E ^a   Sarkar, Moumita ^a   Adams Webber, Thomasin ^a   Koren, Gideon ^a,b,c  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); FOLIC ACID;

CANCER RISK; COLORECTAL CANCER; DATA BASE; DNA POLYMORPHISM; DNA STRAND BREAKAGE; EMBASE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MEDLINE; META ANALYSIS; OBSERVATIONAL STUDY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK REDUCTION; SYSTEMATIC REVIEW;

EID: 84869054092     PISSN: 16878558     EISSN: 16878566     Source Type: Journal    
DOI: 10.1155/2012/952508     Document Type: Review

References (100)

1. Jemal A., Bray F., Center M. M., Ferlay J., Ward E., Forman D., Global cancer statistics. CA Cancer Journal for Clinicians 2011 61 2 69 90 2-s2.0-79952232216 10.3322/caac.20107
2. Center M. M., Jemal A., Smith R. A., Ward E., Worldwide variations in colorectal cancer. CA Cancer Journal for Clinicians 2009 59 6 366 378 2-s2.0-73049112438 10.3322/caac.20038
3. Migliore L., Migheli F., Spisni R., Copped F., Genetics, cytogenetics, and epigenetics of colorectal cancer. Journal of Biomedicine and Biotechnology 2011 2011 19 2-s2.0-79953272159 10.1155/2011/792362 792362
4. Kim Y. I., Role of folate in colon cancer development and progression. Journal of Nutrition 2003 133 11, supplement 1 3731S 3739S 2-s2.0-0242610825
5. Ames B. N., DNA damage from micronutrient deficiencies is likely to be a major cause of cancer. Mutation ResearchFundamental and Molecular Mechanisms of Mutagenesis 2001 475 1-2 7 20 2-s2.0-0035906343 10.1016/S0027-5107(01)00070-7 (Pubitemid 32284938)
6. Duthie S. J., Folic acid deficiency and cancer: mechanisms of DNA instability. British Medical Bulletin 1999 55 3 578 592 2-s2.0-0032713838
7. Fenech M., The role of folic acid and Vitamin B12 in genomic stability of human cells. Mutation ResearchFundamental and Molecular Mechanisms of Mutagenesis 2001 475 1-2 57 67 2-s2.0-0035906327 10.1016/S0027-5107(01)00079-3 (Pubitemid 32280803)
8. Ryan B. M., Weir D. G., Relevance of folate metabolism in the pathogenesis of colorectal cancer. Journal of Laboratory and Clinical Medicine 2001 138 3 164 176 2-s2.0-0034868436 10.1067/mlc.2001.117161 (Pubitemid 32812229)
9. Mukherjee M., Joshi S., Bagadi S., Dalvi M., Rao A., Shetty K. R., A low prevalence of the C677T mutation in the methylenetetrahydrofolate reductase gene in Asian Indians. Clinical Genetics 2002 61 2 155 159 2-s2.0-0036488108 10.1034/j.1399-0004.2002.610212.x (Pubitemid 36372622)
10. Ulrich C. M., Robien K., Sparks R., Pharmacogenetics and folate metabolisma promising direction. Pharmacogenomics 2002 3 3 299 313 2-s2.0-0036265638 10.1517/14622416.3.3.299 (Pubitemid 34567568)
11. Robien K., Boynton A., Ulrich C. M., Pharmacogenetics of folate-related drug targets in cancer treatment. Pharmacogenomics 2005 6 7 673 689 2-s2.0-26944497848 10.2217/14622416.6.7.673 (Pubitemid 41479413)
12. Guéant-Rodriguez R. M., Guéant J. L., Debard R., Thirion S., Lu X. H., Bronowicki J. P., Namour F., Chabi N. W., Sanni A., Anello G., Bosco P., Romano C., Amouzou E., Arrieta H. R., Sánchez B. E., Romano A., Herbeth B., Guilland J. C., Mutchinick O. M., Prevalence of methylenetetrahydrofolate reductase 677T and 1298C alleles and folate status: a comparative study in Mexican, West African, and European populations. American Journal of Clinical Nutrition 2006 83 3 701 707 2-s2.0-33645652119 (Pubitemid 44699219)
13. Wilcken B., Bamforth F., Li Z., Zhu H., Ritvanen A., Redlund M., Stoll C., Alembik Y., Dott B., Czeizel A. E., Gelman-Kohan Z., Scarano G., Bianca S., Ettore G., Tenconi R., Bellato S., Scala I., Mutchinick O. M., López M. A., de Walle H., Hofstra R., Joutchenko L., Kavteladze L., Bermejo E., Martínez-Frías M. L., Gallagher M., Erickson J. D., Vollset S. E., Mastroiacovo P., Andria G., Botto L. D., Geographical and ethnic variation of the 677 C > T allele of 5, 10 methylenetetrahydrofolate reductase (MTHFR): findings from over 7000 newborns from 16 areas world wide. Journal of Medical Genetics 2003 40 8 619 625 2-s2.0-0041326346 (Pubitemid 37046918)
14. Chandy S., Adiga M. N. S., Ramachandra N., Krishnamoorthy S., Ramaswamy G., Savithri H. S., Krishnamoorthy L., Association of methylenetetrahydrofolate reductase gene polymorphisms & colorectal cancer in India. Indian Journal of Medical Research 2010 131 5 659 664 2-s2.0-77952412007
15. Delgado-Enciso I., Martínez-Garza S. G., Rojas-Martínez A., Ortiz-López R., Bosques-Padilla F., Calderón-Garcidueas A. L., Zárate-Gómez M., Barrera-Saldaa H. A., 677T mutation of the MTHFR gene in adenomas and colorectal cancer in a population sample from the Northeastern Mexico. Preliminary results. Revista de Gastroenterologia de Mexico 2001 66 1 32 37 2-s2.0-18144436225
16. Matsuo K., Hamajima N., Hirai T., Methionine synthase reductase gene A66G polymorphism is associated with risk of colorectal cancer. Asian Pacific Journal of Cancer Prevention 2002 3 4 353 359
17. Zeybek U., Yaylim I., Yilmaz H., Aahan B., Ergen A., Arikan S., Bayrak S., Isbir T., Methylenetetrahydrofolate reductase C677T polymorphism in patients with gastric and colorectal cancer. Cell Biochemistry and Function 2007 25 4 419 422 2-s2.0-34447544092 10.1002/cbf.1317 (Pubitemid 47066718)
18. Iacopetta B., Heyworth J., Girschik J., Grieu F., Clayforth C., Fritschi L., The MTHFR C677T and ΔDNMT3B C-149T polymorphisms confer different risks for right- and left-sided colorectal cancer. International Journal of Cancer 2009 125 1 84 90 2-s2.0-66149137224 10.1002/ijc.24324
19. Botto L. D., Yang Q., 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. American Journal of Epidemiology 2000 151 9 862 877 2-s2.0-0034190659 (Pubitemid 30461127)
20. Ulvik A., Vollset S. E., Hansen S., Gislefoss R., Jellum E., Ueland P. M., Colorectal cancer and the methylenetetrahydrofolate reductase 677C→T and methionine synthase 2756A→G polymorphisms: a study of 2,168 case-control pairs from the JANUS cohort. Cancer Epidemiology Biomarkers and Prevention 2004 13 12 2175 2180 2-s2.0-11144236628 (Pubitemid 40054314)
21. Yin G., Kono S., Toyomura K., Hagiwara T., Nagano J., Mizoue T., Mibu R., Tanaka M., Kakeji Y., Maehara Y., Okamura T., Ikejiri K., Futami K., Yasunami Y., Maekawa T., Takenaka K., Ichimiya H., Imaizumi N., Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and colorectal cancer: the Fukuoka Colorectal Cancer study. Cancer Science 2004 95 11 908 913 2-s2.0-19944366586 10.1111/j.1349-7006.2004.tb02201.x (Pubitemid 40045526)
22. Haghighi M. M., Radpour R., Mahmoudi T., Mohebbi S. R., Vahedi M., Zali M. R., Association between MTHFR polymorphism (C677T) with nonfamilial colorectal cancer. Oncology Research 2009 18 2-3 57 63 2-s2.0-75649101266 10.3727/096504009789954636
23. Le Marchand L., Donlon T., Hankin J. H., Kolonel L. N., Wilkens L. R., Seifried A., B-vitamin intake, metabolic genes, and colorectal cancer risk (United States). Cancer Causes and Control 2002 13 3 239 248 2-s2.0-0036230697 10.1023/A:1015057614870 (Pubitemid 34438233)
24. van Guelpen B., Dahlin A. M., Hultdin J., Eklöf V., Johansson I., Henriksson M. L., Cullman I., Hallmans G., Palmqvist R., One-carbon metabolism and CpG island methylator phenotype status in incident colorectal cancer: a nested case-referent study. Cancer Causes and Control 2010 21 4 557 566 2-s2.0-77953293058 10.1007/s10552-009-9484-y
25. Pardini B., Kumar R., Naccarati A., Prasad R. B., Forsti A., Polakova V., Vodickova L., Novotny J., Hemminki K., Vodicka P., MTHFR and MTRR genotype and haplotype analysis and colorectal cancer susceptibility in a case-control study from the Czech Republic. Mutation ResearchGenetic Toxicology and Environmental Mutagenesis 2011 721 1 74 80 2-s2.0-79951669632 10.1016/j.mrgentox.2010.12.008
26. Kim J. W., Park H. M., Choi Y. K., Chong S. Y., Oh D., Kim N. K., Polymorphisms in genes involved in folate metabolism and plasma DNA methylation in colorectal cancer patients. Oncology Reports 2011 25 1 167 172 2-s2.0-78650749244 10.3892/or-00001057
27. Kim J., Cho Y. A., Kim D. H., Lee B. H., Hwang D. Y., Jeong J., Lee H. J., Matsuo K., Tajima K., Ahn Y. O., Dietary intake of folate and alcohol, MTHFR C677T polymorphism, and colorectal cancer risk in Korea. American Journal of Clinical Nutrition 2012 95 2 405 412 2-s2.0-84856388042 10.3945/ajcn.111.020255
28. Cui L. H., Shin M. H., Kweon S. S., Kim H. N., Song H. R., Piao J. M., Choi J. S., Shim H. J., Hwang J. E., Kim H. R., Park Y. K., Kim S. H., Methylenetetrahydrofolate reductase C677T polymorphism in patients with gastric and colorectal cancer in a Korean population. BMC Cancer 2010 10, article 236 2-s2.0-77952641690 10.1186/1471-2407-10-236
29. Zhu Q., Jin Z., Yuan Y., Lu Q., Ge D., Zong M., Impact of MTHFR gene C677T polymorphism on Bcl-2 gene methylation and protein expression in colorectal cancer. Scandinavian Journal of Gastroenterology 2011 46 4 436 445 2-s2.0-79952585264 10.3109/00365521.2010.537682
30. Gallegos-Arreola M. P., García-Ortiz J. E., Figuera L. E., Puebla-Pérez A. M., Morgan-Villela G., Zúiga-González G. M., Association of the 677C→T polymorphism in the MTHFR gene with colorectal cancer in Mexican patients. Cancer Genomics and Proteomics 2009 6 3 183 188 2-s2.0-67649494692
31. Guerreiro C. S., Carmona B., Gonalves S., Carolino E., Fidalgo P., Brito M., Leitão C. N., Cravo M., Risk of colorectal cancer associated with the C677T polymorphism in 5,10-methylenetetrahydrofolate reductase in Portuguese patients depends on the intake of methyl-donor nutrients. American Journal of Clinical Nutrition 2008 88 5 1413 1418 2-s2.0-55849091713 10.3945/ajcn.2008. 25877
32. Bailey L. B., Folate in Health and Disease 2010 2nd Boca Raton, Fla, USA Taylor & Francis
33. Sharp L., Little J., Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: a HuGE review. American Journal of Epidemiology 2004 159 5 423 443 2-s2.0-1442300286 10.1093/aje/kwh066 (Pubitemid 38280289)
34. Park K. S., Mok J. W., Kim J. C., The 677 C > T mutation in 5,10-methylenetetrahydrofolate reductase and colorectal cancer risk. Genetic Testing 1999 3 2 233 236 2-s2.0-0032799527 (Pubitemid 29344718)
35. Keku T., Millikan R., Worley K., Winkel S., Eaton A., Biscocho L., Martin C., Sandier R., 5,10-Methylenetetrahydrofolate reductase codon 677 and 1298 polymorphisms and colon cancer in African Americans and whites. Cancer Epidemiology Biomarkers and Prevention 2002 11 12 1611 1621 2-s2.0-0036907435 (Pubitemid 36020015)
36. Shannon B., Gnanasampanthan S., Beilby J., Iacopetta B., A polymorphism in the methylenetetrahydrofolate reductase gene predisposes to colorectal cancers with microsatellite instability. Gut 2002 50 4 520 524 2-s2.0-0036278536 10.1136/gut.50.4.520 (Pubitemid 34638872)
37. Plaschke J., Schwanebeck U., Pistorius S., Saeger H. D., Schackert H. K., Methylenetetrahydrofolate reductase polymorphisms and risk of sporadic and hereditary colorectal cancer with or without microsatellite instability. Cancer Letters 2003 191 2 179 185 2-s2.0-0344642951 10.1016/S0304-3835(02)00633-X (Pubitemid 36255603)
38. Pufulete M., Al-Ghnaniem R., Leather A. J. M., Appleby P., Gout S., Terry C., Emery P. W., Sanders T. A. B., Folate status, genomic DNA hypomethylation, and risk of colorectal adenoma and cancer: a case control study. Gastroenterology 2003 124 5 1240 1248 2-s2.0-0038523843 10.1016/S0016-5085(03) 00279-8 (Pubitemid 36531800)
39. Toffoli G., Gafà R., Russo A., Lanza G., Dolcetti R., Sartor F., Libra M., Viel A., Boiocchi M., Methylenetetrahydrofolate reductase 677 C→T polymorphism and risk of proximal colon cancer in North Italy. Clinical Cancer Research 2003 9 2 743 748 2-s2.0-0037312526 (Pubitemid 36182609)
40. Jiang Q. T., Chen K., Ma X. Y., Miao X. P., Yao K. Y., Yu W. P., Li L. Y., Zhu Y. M., Zhou H. G., A case-control study on the polymorphisms of methylenetetrahydrofolate reductases, drinking interaction and susceptibility in colorectal cancer. Chinese Journal of Epidemiology 2004 25 7 612 616 2-s2.0-21644474676
41. Miao X. P., Yang S., Tan W., Zhang X. M., Ye Y. J., Lin D. X., Wang S., Association between genetic variations in methylenetetrahydrofolate reductase and risk of colorectal cancer in a Chinese population. Chinese Journal of Preventive Medicine 2005 39 6 409 411 2-s2.0-33745818711
42. Jiang Q., Chen K., Ma X., Li Q., Yu W., Shu G., Yao K., Diets, polymorphisms of methylenetetrahydrofolate reductase, and the susceptibility of colon cancer and rectal cancer. Cancer Detection and Prevention 2005 29 2 146 154 2-s2.0-17144420868 10.1016/j.cdp.2004.11.004 (Pubitemid 40514391)
43. Landi S., Gemignani F., Moreno V., Gioia-Patricola L., Chabrier A., Guino E., Navarro M., de Oca J., Capellà G., Canzian F., Moreno V., Navarro M., Marti-Ragué J., de Oca J., Osorio A., Del Rio C., Biondo S., Cambray M., Vilardell F., Lloveras B., MaBadosa J., Guino E., Pareja L., Pontes C., Peinado M. A., Capella G., A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of colorectal cancer. Pharmacogenetics and Genomics 2005 15 8 535 546 2-s2.0-22944443568 (Pubitemid 41044239)
44. Matsuo K., Ito H., Wakai K., Hirose K., Saito T., Suzuki T., Kato T., Hirai T., Kanemitsu Y., Hamajima H., Tajima K., One-carbon metabolism related gene polymorphisms interact with alcohol drinking to influence the risk of colorectal cancer in Japan. Carcinogenesis 2005 26 12 2164 2171 2-s2.0-27944455699 10.1093/carcin/bgi196 (Pubitemid 41672204)
45. Otani T., Iwasaki M., Hanaoka T., Kobayashi M., Ishihara J., Natsukawa S., Shaura K., Koizumi Y., Kasuga Y., Yoshimura K., Yoshida T., Tsugane S., Folate, vitamin B6, vitamin B12, and vitamin B 2 intake, genetic polymorphisms of related enzymes, and risk of colorectal cancer in a hospital-based case-control study in Japan. Nutrition and Cancer 2005 53 1 42 50 2-s2.0-30344440353 10.1207/s15327914nc53015 (Pubitemid 43068552)
46. Le Marchand L., Wilkens L. R., Kolonel L. N., Henderson B. E., The MTHFR C677T polymorphism and colorectal cancer: the multiethnic cohort study. Cancer Epidemiology Biomarkers and Prevention 2005 14 5 1198 1203 2-s2.0-18544376080 10.1158/1055-9965.EPI-04-0840 (Pubitemid 40656467)
47. Battistelli S., Vittoria A., Stefanoni M., Bing C., Roviello F., Total plasma homocysteine and methylenetetrahydrofolate reductase C677T polymorphism in patients with colorectal carcinoma. World Journal of Gastroenterology 2006 12 38 6128 6132 2-s2.0-33750614452 (Pubitemid 44688160)
48. Wang J., Gajalakshmi V., Jiang J., Kuriki K., Suzuki S., Nagaya T., Nakamura S., Akasaka S., Ishikawa H., Tokudome S., Associations between 5,10-methylenetetrahydrofolate reductase codon 677 and 1298 genetic polymorphisms and environmental factors with reference to susceptibility to colorectal cancer: a case-control study in an Indian population. International Journal of Cancer 2006 118 4 991 997 2-s2.0-31544481440 10.1002/ijc.21438 (Pubitemid 43157676)
49. Lima C. S. P., Nascimento H., Bonadia L. C., Teori M. T., Coy C. S. R., Góes J. R. N., Costa F. E., Bertuzzo C. S., Polymorphisms in methylenetetrahydrofolate reductase gene (MTHFR) and the age of onset of sporadic colorectal adenocarcinoma. International Journal of Colorectal Disease 2007 22 7 757 763 2-s2.0-34249951407 10.1007/s00384-006-0237-z (Pubitemid 46876192)
50. Chang S. C., Lin P. C., Lin J. K., Yang S. H., Wang H. S., Fen-Yau Li A., Role of MTHFR polymorphisms and folate levels in different phenotypes of sporadic colorectal cancers. International Journal of Colorectal Disease 2007 22 5 483 489 2-s2.0-33947685362 10.1007/s00384-006-0190-x (Pubitemid 46488052)
51. Curtin K., Slattery M. L., Ulrich C. M., Bigler J., Levin T. R., Wolff R. K., Albertsen H., Potter J. D., Samowitz W. S., Genetic polymorphisms in one-carbon metabolism: associations with CpG island methylator phenotype (CIMP) in colon cancer and the modifying effects of diet. Carcinogenesis 2007 28 8 1672 1679 2-s2.0-34548178346 10.1093/carcin/bgm089 (Pubitemid 47303944)
52. Hubner R. A., Lubbe S., Chandler I., Houlston R. S., MTHFR C677T has differential influence on risk of MSI and MSS colorectal cancer. Human Molecular Genetics 2007 16 9 1072 1077 2-s2.0-34447527602 10.1093/hmg/ddm055 (Pubitemid 47064315)
53. Jin X. X., Zhu Z. Z., Wang A. Z., Jia H. R., Association of methylenetetrahydrofolate reductase C677T polymorphism with genetic susceptibility to colorectal cancer World Chinese Journal of Digestology 2007 15 25 2754 2757 2-s2.0-36849092819
54. Murtaugh M. A., Curtin K., Sweeney C., Wolff R. K., Holubkov R., Caan B. J., Slattery M. L., Dietary intake of folate and co-factors in folate metabolism, MTHFR polymorphisms, and reduced rectal cancer. Cancer Causes and Control 2007 18 2 153 163 2-s2.0-33846816918 10.1007/s10552-006-0099-2 (Pubitemid 46215312)
55. Osian G., Procopciuc L., Vlad L., MTHFR polymorphisms as prognostic factors in sporadic colorectal cancer. Journal of Gastrointestinal and Liver Diseases 2007 16 3 251 256 2-s2.0-34948905809 (Pubitemid 47518386)
56. Cao H. X., Gao C. M., Takezaki T., Wu J. Z., Ding J. H., Liu Y. T., Li S. P., Su P., Cao J., Hamajima N., Tajima K., Genetic polymorphisms of methylenetetrahydrofolate reductase and susceptibility to colorectal cancer. Asian Pacific Journal of Cancer Prevention 2008 9 2 203 208 2-s2.0-59849117424
57. Küry S., Buecher B., Robiou-du-Pont S., Scoul C., Colman H., Le Neel T., Le Houérou C., Faroux R., Ollivry J., Lafraise B., Chupin L. D., Sébille V., Bézieau S., Low-penetrance alleles predisposing to sporadic colorectal cancers: a French case-controlled genetic association study. BMC Cancer 2008 8, article 326 2-s2.0-56849112856 10.1186/1471-2407-8-326
58. Lightfoot T. J., Barrett J. H., Bishop T., Northwood E. L., Smith G., Wilkie M. J. V., Steele R. J. C., Carey F. A., Key T. J., Wolf R., Forman D., Methylene tetrahydrofolate reductase genotype modifies the chemopreventive effect of folate in colorectal adenoma, but not colorectal cancer. Cancer Epidemiology Biomarkers and Prevention 2008 17 9 2421 2430 2-s2.0-53349127456 10.1158/1055-9965.EPI-08-0058
59. Mokarram P., Naghibalhossaini F., Saberi Firoozi M., Hosseini S. V., Izadpanah A., Salahi H., Malek-Hosseini S. A., Talei A., Mojallal M., Methylenetetrahydrofolate reductase C677T genotype affects promoter methylation of tumor-specific genes in sporadic colorectal cancer through an interaction with folate/vitamin B12 status. World Journal of Gastroenterology 2008 14 23 3662 3671 2-s2.0-54349091339 10.3748/wjg.14.3662
60. Sharp L., Little J., Brockton N. T., Cotton S. C., Masson L. F., Haites N. E., Cassidy J., Polymorphisms in the methylenetetrahydrofolate reductase (MTHFR) gene, intakes of folate and related B vitamins and colorectal cancer: a case-control study in a population with relatively low folate intake. British Journal of Nutrition 2008 99 2 379 389 2-s2.0-38049119388 10.1017/ S0007114507801073
61. Theodoratou E., Farrington S. M., Tenesa A., McNeill G., Cetnarskyj R., Barnetson R. A., Porteous M. E., Dunlop M. G., Campbell H., Dietary vitamin B6 intake and the risk of colorectal cancer. Cancer Epidemiology Biomarkers and Prevention 2008 17 1 171 182 2-s2.0-38849101488 10.1158/1055-9965.EPI-07-0621 (Pubitemid 351196288)
62. Zhang Y. L., Yuan X. Y., Zhang Z., Yang H., Zhou Y. H., Pan Y. M., Zhou Z. Y., Liang H. J., Cao J., Relationship of genetic polymorphisms in methylenetetrahydrofolate reductase and alcohol drinking with the risk of colorectal cancer Chinese Journal of Cancer Prevention and Treatment 2008 15 17 1298 1301 2-s2.0-77953426607
63. El Awady M. K., Karim A. M., Hanna L. S., El Husseiny L. A., El Sahar M., Menem H. A. A., Meguid N. A., Methylenetetrahydrofolate reductase gene polymorphisms and the risk of colorectal carcinoma in a sample of Egyptian individuals. Cancer Biomarkers 2009 5 6 233 240 2-s2.0-76749104337 10.3233/CBM-2009-0108
64. Eussen S. J. P. M., Vollset S. E., Igland J., Meyer K., Fredriksen Å., Ueland P. M., Jenab M., Slimani N., Boffetta P., Overvad K., Tjonneland A., Olsen A., Clavel-Chapelon F., Boutron-Ruault M.-C., Morois S., Weikert C., Pischon T., Linseisen J., Kaaks R., Trichopoulou A., Zilis D., Katsoulis M., Palli D., Berrino F., Vineis P., Tumino R., Panico S., Peeters P. H. M., Bueno-de-Mesquita H. B., van Duijnhoven F. J. B., Gram I. T., Skeie G., Lund E., González C. A., Martínez C., Dorronsoro M., Ardanaz E., Navarro C., Rodríguez L., van Guelpen B., Palmqvist R., Manjer J., Ericson U., Bingham S., Khaw K.-T., Norat T., Riboli E., Plasma folate, related genetic variants, and colorectal cancer risk in EPIC. Cancer Epidemiology Biomarkers and Prevention 2010 19 5 1328 1340 2-s2.0-77952019974 10.1158/1055-9965.EPI-09-0841
65. Fernández-Peralta A. M., Daimiel L., Nejda N., Iglesias D., Medina Arana V., González-Aguilera J. J., Association of polymorphisms MTHFR C677T and A1298C with risk of colorectal cancer, genetic and epigenetic characteristic of tumors, and response to chemotherapy. International Journal of Colorectal Disease 2010 25 2 141 151 2-s2.0-77649235525 10.1007/s00384-009- 0779-y
66. Karpinski P., Myszka A., Ramsey D., Misiak B., Gil J., Laczmanska I., Grzebieniak Z., Sebzda T., Smigiel R., Stembalska A., Sasiadek M. M., Polymorphisms in methyl-group metabolism genes and risk of sporadic colorectal cancer with relation to the CpG island methylator phenotype. Cancer Epidemiology 2010 34 3 338 344 2-s2.0-77952243371 10.1016/j.canep.2010.03.002
67. Komlósi V., Hitre E., Pap É., Adleff V., Réti A., Székely É., Bíró A., Rudnai P., Schoket B., Müller J., Tóth B., Ottó S., Kásler M., Kralovánszky J., Budai B., SHMT1 1420 and MTHFR 677 variants are associated with rectal but not colon cancer. BMC Cancer 2010 10, article 525 2-s2.0-77957286796 10.1186/1471-2407-10-525
68. Naghibalhossaini F., Mokarram P., Khalili I., Vasei M., Hosseini S. V., Ashktorab H., Rasti M., Abdollahi K., MTHFR C677T and A1298C variant genotypes and the risk of microsatellite instability among Iranian colorectal cancer patients. Cancer Genetics and Cytogenetics 2010 197 2 142 151 2-s2.0-77249090777 10.1016/j.cancergencyto.2009.11.014
69. Promthet S. S., Pientong C., Ekalaksananan T., Wiangnon S., Poomphakwaen K., Songserm N., Chopjitt P., Moore M. A., Tokudome S., Risk factors for colon cancer in northeastern thailand: interaction of MTHFR codon 677 and 1298 genotypes with environmental factors. Journal of Epidemiology 2010 20 4 329 338 2-s2.0-77954922598 10.2188/jea.JE20090140
70. Wettergren Y., Odin E., Nilsson S., MTHFR, MTR, and MTRR polymorphisms in relation to p16 (INK4A) gene promoter hypermethylation in colorectal mucosa and clinical outcome of patients with colorectal cancer. Pteridines 2009 20 3 98 99
71. Abuli A., Fernandez-Rozadilla C., Alonso-Espinaco V., Munoz J., Gonzalo V., Bessa X., Gonzalez D., Clofent J., Cubiella J., Morillas J. D., Rigau J., Latorre M., Fernandez-Banares F., Pena E., Riestra S., Paya A., Jover R., Xicola R. M., Llor X., Carvajal-Carmona L., Villanueva C. M., Moreno V., Pique J. M., Carracedo A., Castells A., Andreu M., Ruiz-Ponte C., Castellvi-Bel S., Case-control study for colorectal cancer genetic susceptibility in EPICOLON: previously identified variants and mucins. BMC Cancer 2011 11, article 339 2-s2.0-79961115811 10.1186/1471-2407-11-339
72. Guimarães J. L. M., Ayrizono M. D. L., Coy C. S. R., Lima C. S. P., Gene polymorphisms involved in folate and methionine metabolism and increased risk of sporadic colorectal adenocarcinoma. Tumor Biology 2011 32 5 853 861 2-s2.0-80052334233 10.1007/s13277-011-0185-2
73. Jokić M., Brić-Kostić K., Stefulj J., Ivković T. C., Boo L., Gamulin M., Kapitanović S., Association of MTHFR, MTR, MTRR, RFC1, and DHFR gene polymorphisms with susceptibility to sporadic colon cancer. DNA and Cell Biology 2011 30 10 771 776 2-s2.0-80053584694
74. Sameer A. S., Shah Z. A., Nissar S., Mudassar S., Siddiqi M. A., Risk of colorectal cancer associated with the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism in the Kashmiri population. Genetics and Molecular Research 2011 10 2 1200 1210 2-s2.0-80053300270 10.4238/vol10-2gmr1067
75. Prasad V. V. T. S., Wilkhoo H., Association of the functional polymorphism C677T in the methylenetetrahydrofolate reductase gene with colorectal, thyroid, breast, ovarian, and cervical cancers. Onkologie 2011 34 8-9 422 426 2-s2.0-80053243541 10.1159/000331131
76. Lee J. E., Wei E. K., Fuchs C. S., Plasma folate, methylenetetrahydrofolate reductase (MTHFR), and colorectal cancer risk in three large nested case-control studies. Cancer Causes and Control 2012 23 4 537 545 10.1007/s10552-012-9911-3
77. de Vogel S., Wouters K. A. D., Gottschalk R. W. H., van Schooten F. J., de Goeij A. F. P. M., de Bruïne A. P., Goldbohm R. A., van Den Brandt P. A., Weijenberg M. P., van Engeland M., Genetic variants of methyl metabolizing enzymes and epigenetic regulators: associations with promoter CpG island hypermethylation in colorectal cancer. Cancer Epidemiology Biomarkers and Prevention 2009 18 11 3086 3096 2-s2.0-72749115699 10.1158/1055-9965.EPI-09-0289
78. Heijmans B. T., Boer J. M. A., Suchiman H. E. D., Cornelisse C. J., Westendorp R. G. J., Kromhout D., Feskens E. J. M., Slagboom P. E., A common variant of the methylenetetrahydrofolate reductase gene (1p36) is associated with an increased risk of cancer. Cancer Research 2003 63 6 1249 1253 2-s2.0-0037444389 (Pubitemid 36348702)
79. Downs S. H., Black N., The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. Journal of Epidemiology and Community Health 1998 52 6 377 384 2-s2.0-0031754739 (Pubitemid 28438523)
80. DerSimonian R., Laird N., Meta-analysis in clinical trials. Controlled Clinical Trials 1986 7 3 177 188 2-s2.0-0022992740 (Pubitemid 17189972)
81. Silman A. J., MacFarlane G. J., Epidemiological Studies: A Practical Guide 2002 2nd New York, NY, USA Cambridge University Press
82. Review Manager (RevMan). The Nordic Cochrane Centre, The Cochrane Collaboration, Copenhagen, Denmark, 2008
83. Hamling J., Lee P., Weitkunat R., Ambühl M., Facilitating meta-analyses by deriving relative effect and precision estimates for alternative comparisons from a set of estimates presented by exposure level or disease category. Statistics in Medicine 2008 27 7 954 970 2-s2.0-40849097739 10.1002/sim.3013 (Pubitemid 351395458)
84. Hamling J., Alternative comparisons from related odds ratios or relative risks: RR Estrelative risk estimation program. P N Lee Statistics and Computing Ltd, 2007
85. Begg C. B., Mazumdar M., Operating characteristics of a rank correlation test for publication bias. Biometrics 1994 50 4 1088 1101 2-s2.0-0028659004 10.2307/2533446
86. Egger M., Smith G. D., Schneider M., Minder C., Bias in meta-analysis detected by a simple, graphical test. British Medical Journal 1997 315 7109 629 634 2-s2.0-0030922816 (Pubitemid 27387172)
87. Duval S., Tweedie R., Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000 56 2 455 463 2-s2.0-0033934949 (Pubitemid 30422636)
88. Borenstein M., Hedges L., Higgins J., Comprehensive Meta-Analysis Version 2.0 2005 Englewood, NJ, USA Biostat
89. Higgins J. T. P., Green S., Cochrane Handbook for Systematic Reviews of Interventions 2008 Hoboken, NJ, USA Wiley-Blackwell
90. Chen J., Giovannucci E., Kelsey K., Rimm E. B., Stampfer M. J., Colditz G. A., Spiegelman D., Willett W. C., Hunter D. J., A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Research 1996 56 21 4862 4864 2-s2.0-0029855024 (Pubitemid 26374419)
91. Slattery M. L., Potter J. D., Samowitz W., Schaffer D., Leppert M., Methylenetetrahydrofolate reductase, diet, and risk of colon cancer. Cancer Epidemiology Biomarkers and Prevention 1999 8 6 513 518 2-s2.0-0033014832 (Pubitemid 29270335)
92. Matevska N., Josifovski T., Kapedanovska A., Sterjev Z., Serafimoska Z., Panovski M., Jankulovski N., Petrusevska N., Angelovska B., Petrusevska G., Suturkova L., Dimovski A. J., Methylenetetrahydrofolate reductase C677T polymorphism and risk of colorectal cancer in the macedonian population. Balkan Journal of Medical Genetics 2008 11 2 17 24 2-s2.0-67549109539 10.2478/v10034-008-0028-7
93. Chen K., Song L., Jin M. J., Fan C. H., Jiang Q. T., Yu W. P., Association between genetic polymorphisms in folate metabolic enzyme genes and colorectal cancer: a nested case-control study. Zhonghua Zhong Liu Za Zhi 2006 28 6 429 432 2-s2.0-38749150021
94. Taioli E., Garza M. A., Ahn Y. O., Bishop D. T., Bost J., Budai B., Chen K., Gemignani F., Keku T., Lima C. S. P., Le Marchand L., Matsuo K., Moreno V., Plaschke J., Pufulete M., Thomas S. B., Toffoli G., Wolf C. R., Moore C. G., Little J., Meta-and pooled analyses of the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and colorectal cancer: a HuGE-GSEC review. American Journal of Epidemiology 2009 170 10 1207 1221 2-s2.0-70350694056 10.1093/aje/kwp275
95. Kono S., Chen K., Genetic polymorphisms of methylenetetrahydrofolate reductase and colorectal cancer and adenoma. Cancer Science 2005 96 9 535 542 2-s2.0-27144526086 10.1111/j.1349-7006.2005.00090.x (Pubitemid 41488416)
96. Patsopoulos N. A., Evangelou E., Ioannidis J. P. A., Sensitivity of between-study heterogeneity in meta-analysis: proposed metrics and empirical evaluation. International Journal of Epidemiology 2008 37 5 1148 1157 2-s2.0-53349173117 10.1093/ije/dyn065
97. Blom H. J., Smulders Y., Overview of homocysteine and folate metabolism. With special references to cardiovascular disease and neural tube defects. Journal of Inherited Metabolic Disease 2011 34 1 75 81 2-s2.0-79955846242 10.1007/s10545-010-9177-4
98. Pitkin R. M., Folate and neural tube defects. American Journal of Clinical Nutrition 2007 85 1 285S 288S 2-s2.0-33846056133 (Pubitemid 46067650)
99. DRI, Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin Bb6s, Folate, Vitamin Bb12s, Pantothenic Acid, Biotin, and Choline 1998 Washington, DC, USA National Academy Press
100. Stevens V. L., McCullough M. L., Sun J., Jacobs E. J., Campbell P. T., Gapstur S. M., High levels of folate from supplements and fortification are not associated with increased risk of colorectal cancer. Gastroenterology 2011 141 1 98.e1 105.e1 2-s2.0-79959971003 10.1053/j.gastro.2011.04.004